Search Results for: UBASH3A

108 interactions involving UBASH3A - ubiquitin associated and SH3 domain containing A found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Symbol Description Pathways Hide Drugs Hide Diseases Hide
Novel BACE2 beta-secretase 2
Novel SLC37A1 solute carrier family 37 member 1
  • Gluconeogenesis
Novel TYR tyrosinase
  • Melanin biosynthesis
  • Regulation of MITF-M-dependent genes involved in pigmentation
  • NADH
  • Azelaic acid
  • Monobenzone
  • Mimosine
  • Hydroquinone
  • Arbutin
  • Hexylresorcinol
  • Oculocutaneous albinism (OCA)
ARRDC1 arrestin domain containing 1
ARRDC3 arrestin domain containing 3
ATF6 activating transcription factor 6
  • ATF4 activates genes in response to endoplasmic reticulum stress
  • ATF6 (ATF6-alpha) activates chaperones
  • ATF6 (ATF6-alpha) activates chaperone genes
  • ATF6 (ATF6-alpha) activates chaperone genes
  • Modulation of host responses by IFN-stimulated genes
  • Pseudoephedrine
BCAR3 BCAR3 adaptor protein, NSP family member
CBLB Cbl proto-oncogene B
  • Antigen processing: Ubiquitination & Proteasome degradation
CBS cystathionine beta-synthase
  • Cysteine formation from homocysteine
  • Metabolism of ingested SeMet, Sec, MeSec into H2Se
  • Pyridoxal phosphate
  • Ademetionine
  • Serine
  • Cysteine
  • Homocystinuria
CCDC33 coiled-coil domain containing 33
CD3E CD3 epsilon subunit of T-cell receptor complex
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
  • Downstream TCR signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Translocation of ZAP-70 to Immunological synapse
  • Generation of second messenger molecules
  • Co-inhibition by PD-1
  • Muromonab
  • Teplizumab
  • Catumaxomab
  • Mosunetuzumab
  • Teclistamab
  • Odronextamab
  • T-B+Severe combined immunodeficiencies (SCIDs), including the following eight diseases: X-linked SCID; Janus kinase-3 (Jak3) deficiency; IL-7 receptor alpha (IL7R alpha) deficiency; IL-2 receptor alpha (IL2R alpha) deficiency; CD45 deficiency; CD3 deficiency; Winged Helix Nude (WHN) deficiency; Immunodeficiency with thynoma
COPS9 COP9 signalosome subunit 9
CUEDC1 CUE domain containing 1
CXXC5 CXXC finger protein 5
  • Estrogen-dependent gene expression
DAZAP2 DAZ associated protein 2
DDIT4L DNA damage inducible transcript 4 like
DISC1 DISC1 scaffold protein
DLG1 discs large MAGUK scaffold protein 1
  • Trafficking of AMPA receptors
  • Unblocking of NMDA receptors, glutamate binding and activation
  • Unblocking of NMDA receptors, glutamate binding and activation
  • Ras activation upon Ca2+ influx through NMDA receptor
  • NrCAM interactions
  • Activation of Ca-permeable Kainate Receptor
  • RAF/MAP kinase cascade
  • Synaptic adhesion-like molecules
  • Assembly and cell surface presentation of NMDA receptors
  • Negative regulation of NMDA receptor-mediated neuronal transmission
  • Long-term potentiation
DLGAP4 DLG associated protein 4
  • Neurexins and neuroligins
  • Neurexins and neuroligins
DNM2 dynamin 2
  • Toll Like Receptor 4 (TLR4) Cascade
  • Retrograde neurotrophin signalling
  • Gap junction degradation
  • Formation of annular gap junctions
  • NOSTRIN mediated eNOS trafficking
  • MHC class II antigen presentation
  • Lysosome Vesicle Biogenesis
  • Golgi Associated Vesicle Biogenesis
  • Recycling pathway of L1
  • Clathrin-mediated endocytosis
  • NGF-stimulated transcription
  • Degradation of CDH1
  • Centronuclear myopathy
  • Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy

Page 1 out of 6 pages